Cancer Monitoring Technology In The Future? - Presented by: The Aol. On Network

This morning, Trovagene (TROV) announced it has entered into a clinical collaboration agreement with the University of Southern California study the effectiveness of the company's cell-free DNA assay. The goal is to show that Trovagene's technology is able to identify the cancer's genomic changes following treatment and to track the progression of the disease.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
HTZ $ 30.33 1.23 ▼ 3.90%
BAC $ 15.52 0.07 ▲ 0.45%
AAPL $ 100.57 0.04 ▲ 0.04%
NOK $ 8.13 0.11 ▲ 1.37%
FOLD $ 5.50 0.93 ▲ 20.35%
JCP $ 10.33 0.08 ▲ 0.78%
IRF $ 39.10 12.54 ▲ 47.21%
GE $ 26.36 0.31 ▲ 1.19%

As of 8/20/2014, 04:04 PM
More Most Active

Latest News Headlines

View All